Transgenomic's D'Silva Resigns From Board; Fluidigm Hires ABI Alumnus to Lead Euro Sales; FDA Promotes Woodcock to New Post; and Others | GenomeWeb
NEW YORK (GenomeWeb News) — Affymetrix has named James Gibson its new financial accounting officer, the company said in a Securities and Exchange Commission filing last week.
 
Affymetrix said that its compensation committee has agreed to offer Gibson a base annual salary of $230,000 and granted him 7,500 restricted shares of the company’s common stock.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.